In this episode of Expose MASH [formerly NASH]—intended for US healthcare professionals only—we take a closer look at the pathophysiology of MASH (metabolic dysfunction-associated steatohepatitis) to understand which patients are at high risk for MASH. Join us as we discuss the systemic dysfunction at the root of MASH and other metabolic disorders, exploring how shared disease pathways can help inform patient identification, screening, and holistic patient management. This episode is brought to you by Novo Nordisk Inc.